A little over a year after winning manufacturing certification for its cell therapy factory-in-a-box, South San Francisco’s Cellares has passed another major production milestone. Cellares’ automated ...
When most people think of cancer care, they rarely associate it with what goes on behind the scenes to create life-saving treatments. For starters, developing cell and gene therapies is pricey, and ...
A $380 million deal between Bristol Myers Squibb and the start-up Cellares is a sign of growing demand for cell and gene therapy manufacturing services. Cellares raised $255 million in a series C ...
History is coming full circle as induced pluripotent stem (iPS) cell-derived cell therapy maker Shinobi Therapeutics links up with Panasonic and Japan’s Kyoto University, where the first mouse iPS ...
The Notch signalling pathway is essential for the development and differentiation of various cell types, including immune cells. Notch ligands can promote T cell differentiation, a key step in ...
Anza, a subscription-based data and analytics software platform, released its Q2 2025 Domestic Content Insights report that reveals trends in domestic manufacturing of solar modules and battery energy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback